Samuel I. Gunderson

Affiliations: 
Rutgers University, New Brunswick, New Brunswick, NJ, United States 
Area:
Molecular Biology, Biochemistry
Google:
"Samuel Gunderson"
Mean distance: (not calculated yet)
 
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Tsang AT, Dudgeon C, Yi L, et al. (2017) U1 Adaptors suppress the KRAS-MYC oncogenic axis in human pancreatic cancer xenografts. Molecular Cancer Therapeutics
Boregowda RK, Medina DJ, Markert E, et al. (2016) The transcription factor RUNX2 regulates receptor tyrosine kinase expression in melanoma. Oncotarget
Carpizo D, Tsang A, Yu X, et al. (2016) 262. Therapeutic Suppression of the KRAS-MYC Oncogenic Axis in Human Pancreatic Cancer Xenografts with U1 Adaptor Oligonucleotide / RGD Peptide Conjugates Molecular Therapy. 24: S104
Richfield E, Prasad K, Brenneman M, et al. (2016) 259. Targeted Gene Silencing by U1 Adaptor Oligonucleotides in Preclinical Models of Parkinson's Disease and Huntington's Disease Molecular Therapy. 24: S102
Li W, You B, Hoque M, et al. (2015) Systematic profiling of poly(A)+ transcripts modulated by core 3' end processing and splicing factors reveals regulatory rules of alternative cleavage and polyadenylation. Plos Genetics. 11: e1005166
Tsang AT, Yu X, Goraczniak R, et al. (2015) 694. Targeting KRAS in Pancreatic Cancer by Gene Silencing with U1 Adaptors Molecular Therapy. 23: S276-S277
Tsang AT, Yu X, Goraczniak R, et al. (2014) Abstract B52: Therapeutic targeting of human KRAS in pancreatic cancer using a novel method of gene-silencing: U1 adaptors Molecular Cancer Research. 12
Luo W, Ji Z, Pan Z, et al. (2013) The conserved intronic cleavage and polyadenylation site of CstF-77 gene imparts control of 3' end processing activity through feedback autoregulation and by U1 snRNP. Plos Genetics. 9: e1003613
Goraczniak R, Wall BA, Behlke MA, et al. (2013) U1 Adaptor Oligonucleotides Targeting BCL2 and GRM1 Suppress Growth of Human Melanoma Xenografts In Vivo. Molecular Therapy. Nucleic Acids. 2: e92
Ho ES, Gunderson SI, Duffy S. (2013) A multispecies polyadenylation site model. Bmc Bioinformatics. 14: S9
See more...